Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 151 Lung Neoplasms 34 Carcinoma 11 Parkinson Disease 4, Autosomal Dominant Lewy Body 10 Neoplasms 9 Neoplasm Metastasis 9 Mesothelioma 5 Adenocarcinoma of Lung 5 Uterine Cervical Neoplasms 4 Thoracic Neoplasms 4 Respiratory Tract Neoplasms 4 Respiratory Tract Diseases 4 Mesothelioma, Malignant 4 Lung Diseases 4 Carcinoma, Bronchogenic 4 Non-squamous Non-small Cell Lung Cancer 3 Non-Squamous Non-Small Cell Lung Cancer 3 Neoplasms by Site 3 NSCLC 3 Bronchial Neoplasms 3 Adenocarcinoma 3 Recurrence 2 Non-Squamous Non-small Cell Lung Cancer 2 Non Small Cell Lung Carcinoma NSCLC 2 Head and Neck Neoplasms 2 Brain Neoplasms 2 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1

Interventions

pembrolizumab 1 aumolertinib 1 anlotinib 1 abivertinib 1 Radiosurgery 1 Pemetrexed 1 Gefitinib 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Advanced Non-small Cell Lung Cancer × Pemetrexed × Clear all

NCT06452277 2026-05-18

SOHO-02

Bayer

Phase 3 Recruiting

Advanced Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡